Items Tagged ‘Stages I-III Rectal Cancer’

July 28th, 2016

Addition of Eloxatin® Following Surgery Delays Cancer Progression in Certain Colorectal Cancers

By

The addition of the chemotherapy combination consisting of Eloxatin (oxalipatin) plus 5-fluorouracil (5 FU) following surgery reduces the risk of cancer progression among patients with deficient mismatch repair (dMMR) stage III colorectal cancer. These results were recently published in the Journal of the National Cancer Institute. Among patients with colorectal cancer that has spread to […]

View full entry

Tags: 5fu, Adjuvant (I-III, A-C) Colon Cancer, Colon Cancer, colorectal cancer, crc, dmmr, eloxatin, mismatch repair, News, oxaliplatin, Rectal Cancer, Stages I-III Rectal Cancer


January 28th, 2016

Vectibix® Improves Survival in Colorectal Cancer, Demonstrates Importance of Tissue Testing

By

The addition of Vectibix® (panitumumab) to best supportive care improves survival over best standard care alone among colorectal cancer patients who have stopped responding to chemotherapy. However, the benefit is only seen with patients who have no RAS mutations, or those with only the KRAS exon 2 mutation. These results were recently presented at the […]

View full entry

Tags: Adjuvant (I-III, A-C) Colon Cancer, Colon Cancer, colorectal cancer, KRAS exon 2, News, panitumumab, Rectal Cancer, Recurrent/Relapsed Rectal Cancer, Stage IV (D)/Relapsed Colon Cancer, Stage IV Rectal Cancer, Stages I-III Rectal Cancer, vectibix


June 11th, 2014

FOLFOX Improves Disease-Free Survival in Stage II and III Rectal Cancer Patients

By

Researchers at the University of Ulsan College of Medicine in South Korea reported that treatment with the FOLFOX chemotherapy regimen in rectal cancer patients improved 3-year disease-free survival over a standard chemotherapy of 5-FU/leucovorin. The ADORE study comprised 321 patients with stage II or III rectal cancer who had had their tumors resected (surgically removed). […]

View full entry

Tags: asco, FOLFOX, News, Rectal Cancer, Stages I-III Rectal Cancer


January 16th, 2008

Chemotherapy for Stage II Colorectal Cancer Improves Survival

By

Chemotherapy for Stage II Colorectal Cancer Improves Survival According to results recently published in Lancet Oncology, chemotherapy for Stage II colorectal cancer appears to provide a modest improvement in survival. Colorectal cancer remains the second leading cause of cancer-related deaths in the United States. Stage II (or B) colorectal cancer refers to cancer that has […]

View full entry

Tags: Adjuvant (I-III, A-C) Colon Cancer, News, Stages I-III Rectal Cancer